Cargando…
Ocular Drug, Gene and Cellular Delivery Systems and Advanced Therapy Medicinal Products
Due to recent advances in science and technology, when the products used in therapy are examined, ophthalmology has a priority in terms of research and development, preclinical and clinical studies of innovative drugs, medical devices and drug-medical device combination products. Liposomes, micelles...
Autores principales: | Eldem, Türkan, Eldem, Bora |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032955/ https://www.ncbi.nlm.nih.gov/pubmed/29988818 http://dx.doi.org/10.4274/tjo.32458 |
Ejemplares similares
-
Ranibizumab therapy for predominantly hemorrhagic neovascular age-related macular degeneration
por: Dikmetas, Ozlem, et al.
Publicado: (2022) -
Hyperbaric Oxygen Therapy in Branch Retinal Artery Occlusion in a 15-Year-Old Boy with Methylenetetrahydrofolate Reductase Mutation
por: Celebi, Ali Riza Cenk, et al.
Publicado: (2015) -
The effect of CFH polymorphisms on the response to the treatment of age-related macular degeneration (AMD) with intravitreal ranibizumab
por: Dikmetas, Ozlem, et al.
Publicado: (2013) -
Advances in Ocular Drug Delivery Systems
por: Silva-Cunha, Armando
Publicado: (2021) -
Ocular Drug Delivery: Advancements and Innovations
por: Tian, Bo, et al.
Publicado: (2022)